Posted in | Nanomedicine

CombiMatrix to Discuss the Development of Cancer Array (CCA) Test for Cancer Screening

CombiMatrix Corporation will hold a conference call to discuss the development of its CombiMatrix Cancer Array (CCA) test for cancer screening. Dr. Amit Kumar, President and CEO of CombiMatrix will host this call and will make a short presentation, followed by Q&A. The CCA test is a cancer screening product with multi-billion dollar market potential. This product is in the R&D pipeline of CombiMatrix. This presentation will provide information about the product, its current development stage, its market potential, and other relevant information.

The presentation will start at 2 p.m. Pacific Time (5 p.m. Eastern) on Tuesday, October 7, 2008. To attend the conference call, dial the access number 1-800-868-1837 for domestic callers and 1-404-920-6604 for direct dial or international callers. Enter the Conference Code 85329577 followed by the # sign (85329577#). To view the slide presentation concurrently with the conference call click on the following link (or copy it to your URL): Enter the Conference Code 85329577 and click "Join." The live call, including the slide presentation, may also be accessed on CombiMatrix's website at, in the Investor/Events section, where playback will be available for 30 days beginning October 8, 2008.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback